CONOCOPHILLIPS financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CONOCOPHILLIPS files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	24,360	32,584	38,727	36,670	18,784	45,828	78,494	56,141	54,745	58,944
Cost of revenue	9,994	12,475	14,294	11,842	8,078	18,158	33,971	21,975	20,012	22,325
Gross profit	14,366	20,109	24,433	24,828	10,706	27,670	44,523	34,166	34,733	36,619
Research and development	116	100	78	82	75	62	71	81	81	78
Selling, general and administrative	473	427	401	556	430	719	623	705	1,158	893
Interest expense	1,279	1,114	838	799	788	887	791	824	941	1,176
Interest income	57	112	97	166	100	33	195	412	402	311
Other non-operating income	255	529	173	1,358	-13	-102	47	-2	-181	-20
Pre-tax income	-5,530	-2,615	9,973	9,524	-3,140	12,712	28,228	16,288	13,672	12,656
Income tax	-1,971	-1,822	3,668	2,267	-485	4,633	9,548	5,331	4,427	4,668
Income from continuing operations	-3,615
Net income to minority interests	56	62	48	68	46	0	0
Net income	-3,615	-855	6,257	7,189	-2,701	8,079	18,680	10,957	9,245	7,988
EPS, basic	-2.91	-0.70	5.36	6.43	-2.51	6.09	14.62	9.08	7.82	6.36
EPS, diluted	-2.91	-0.70	5.36	6.40	-2.51	6.07	14.57	9.06	7.81	6.35
Shares, basic (weighted)	1.25	1.22	1.17	1.12	1,078	1,324	1,274	1,203	1,179	1,252
Shares, diluted (weighted)	1.25	1.22	1.18	1.12	1,078	1,328	1,278	1,206	1,181	1,253
Dividend per share	1.00	1.06	1.16	1.34	1.69	1.75	1.89	2.11	2.52	3.18

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	3,610	6,325	5,915	5,088	2,991	5,028	6,458	5,635	5,607	6,497
Short-term investments	50	1,873	248	3,028	3,609		2,785	971	507	484
Receivables	3,414	4,320	4,067	3,401
Inventory	1,018	1,060	1,007	1,026	1,002	1,208	1,219	1,398	1,809	1,873
Other current assets	517	1,035	575	2,259	454	1,581	1,199	852	1,029	865
Total current assets	8,609	16,512	13,274	16,913	12,066	16,050	18,749	14,330	15,647	15,532
Property, plant and equipment	58,331	45,683	45,698	42,269	39,893	64,911	64,866	70,044	94,356	93,239
Lease right-of-use assets			57				536	691	1,017	950
Long-term investments					217	248	522	989	1,055	1,148
Other non-current assets	1,160	1,107	1,344	2,426	2,528	2,587	1,989	2,420	2,908	2,983
Total assets	89,772	73,362	69,980	70,514	62,618	90,661	93,829	95,924	122,780	121,939
Accounts payable	3,631	4,009	3,863	3,176	2,669	5,002	6,113		6,044	6,218
Accrued liabilities	689	725	809	663	608	755	728	774	1,087	1,136
Deferred revenue					97	50
Short-term debt	1,089	2,575	112	105	619	1,200	417	1,074	1,035	1,020
Total current liabilities	6,909	9,397	7,395	7,043	5,366	12,021	12,847	10,005	12,124	11,972
Long-term debt	26,186	17,128	14,856	14,790	14,750	18,734	16,226	17,863	23,289	22,424
Total liabilities	54,546	42,561	37,916	35,464	32,769	45,255	45,826	46,645	57,984	57,452
Total debt	27,275	22,435	16,147	18,108	19,106	18,734	16,226	17,863	23,289	22,424
Paid-in capital	46,507	46,622	46,879	46,983	47,133	60,581	61,142	61,303	77,529	77,728
Retained earnings	31,548	29,391	34,010	39,742	35,213	40,674	53,029	59,268	64,869	68,864
Treasury stock	-36,906	-39,906	-42,905	-46,405	-47,297	-50,920	-60,189	-65,640	-71,152	-76,217
Other comprehensive income	-6,193	-5,518	-6,063	-5,357	-5,218	-4,950	-6,000	-5,673	-6,473	-5,911
Shareholders' equity	34,974	30,607	31,939	34,981	29,849	45,406	48,003	49,279	64,796	64,487
Minority interests	252	194	125	69	0
Total equity	35,226	30,801	32,064	35,050	29,849	45,406	48,003	49,279	64,796	64,487
Total liabilities and equity	89,772	73,362	69,980	70,514	62,618	90,661	93,829	95,924	122,780	121,939

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-3,559	-793	6,305	7,257	-2,655	8,079	18,680	10,957	9,245	7,988
Depreciation and amortization	9,062	6,845	5,956	6,090	5,521	7,208	7,504	8,270	9,599	11,500
Stock-based compensation	272	227	265	274	159	304	377	334	268	336
Deferred income tax	-2,221	-3,681	283	-444	-834	1,346	2,086	1,145	367	549
Change in receivables	820	-886	235	505	521	-2,500	-963	1,333	-262	803
Change in inventory	44	-55	86	-67	-25	-160	-38	-103	-68	-116
Change in payables	-524	265	-52	-378	-249	1,399	901	-1,118	-543	-212
Cash from operations	4,403	7,077	12,934	11,104	4,802	16,996	28,314	19,965	20,124	19,796
Capital expenditures	-4,869	-4,591	-6,750	-6,636	-4,715	-5,324	-10,159
Acquisitions				0	0	-8,290	-60	-2,724	-24	0
Purchases of investments	-1,753	-6,617	-1,953	-4,902	-12,435	-5,554	-5,046	-1,463	-2,606	-1,249
Cash from investing	-3,859	7,762	-3,843	-6,618	-4,121	-8,544	-8,741	-12,000	-11,150	-8,836
Debt issued	4,594	0	0	0	300	0	2,897	3,787	5,591	0
Debt repaid	-2,251	-7,876	-4,995	-80	-254	-505	-6,267	-1,379	-4,981	-913
Stock issued	-63	-63	121	-30	-5	145	362	-52	-78	-100
Share buybacks	-126	-3,000	-2,999	-3,500	-892	-3,623	-9,270	-5,400	-5,463	-5,018
Dividends paid	-1,253	-1,305	-1,363	-1,500	-1,831	-2,359	-5,726	-5,583	-3,646	-3,995
Cash from financing	764	-12,356	-9,359	-5,229	-2,708	-6,335	-18,053	-8,661	-8,835	-10,102
Exchange rate effect	-66	232	-117	-46	-20	-34	-224	-99	-133	153
Net change in cash	1,242	2,715	-385	-789	-2,047	2,083	1,296	-795	6	1,011
Free cash flow	-466	2,486	6,184	4,468	87	11,672	18,155
Interest paid	1,151	1,163	772	810	785	924	873	701	806	757
Income taxes paid	-318	1,168	2,976	2,905	905	856	7,368	5,406	3,621	4,822

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $127.30 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	62.0%	Gross profit / revenue.
Pre-tax margin	23.1%	Pre-tax income / revenue.
Net margin	14.7%	Net income / revenue.
Operating cash flow margin	34.6%	Cash from operations / revenue.
Effective tax rate	36.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.5%	Net income / average total assets.
SG&A / revenue	1.3%	Selling, general and administrative expense / revenue.
D&A / revenue	18.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-9.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	25.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-6.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	27.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-13.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-24.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-18.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-24.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-1.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-11.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	32.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	26.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	18.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	13.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-0.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	9.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	14.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	6.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.54x	Current assets / current liabilities.
Quick ratio	0.62x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.62x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.35x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.4%	Total debt / total assets.
Liabilities / assets	47.4%	Total liabilities / total assets.
Net debt	$15.14B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$6.74B	Current assets - current liabilities.
Tangible book value	$65.35B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.51x	Revenue / average total assets.
Fixed asset turnover	0.69x	Revenue / average property, plant and equipment.
Inventory turnover	12.8x	Cost of revenue / average inventory.
Days inventory	29 days	365 x average inventory / cost of revenue.
Days payables	103 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$7.64	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$52.17	Revenue / diluted weighted shares.
Operating cash flow per share	$18.06	Cash from operations / diluted weighted shares.
Book value per share	$53.82	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$53.82	Tangible book value / shares outstanding.
Cash per share	$6.33	(Cash + short-term investments) / shares outstanding.
Payout ratio	43.8%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$152.93B	Share price x shares outstanding.
Enterprise value	$168.07B	Market cap + total debt - cash - short-term investments.
P/E	16.5x	Market cap / net income. Only when net income is positive.
P/S	2.41x	Market cap / revenue.
P/B	2.34x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.34x	Market cap / tangible book value, when positive.
P/OCF	6.98x	Market cap / cash from operations, when positive.
EV/Sales	2.65x	Enterprise value / revenue.
Earnings yield	6.1%	Net income / market cap (the inverse of P/E).
Dividend yield	2.7%	Dividends paid over the period / market cap.
Shareholder yield	6.1%	(Dividends paid + share buybacks) / market cap.

What was CONOCOPHILLIPS's revenue in fiscal 2025?

CONOCOPHILLIPS reported revenue of $58.94B for fiscal 2025, 7.7% higher than the year before.

Was CONOCOPHILLIPS profitable in fiscal 2025?

Yes. Net income was $7.99B, a net margin of 13.6%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CONOCOPHILLIPS